Radiometal Complexes as Pharmacokinetic Modifiers: A Potent <sup>68</sup>Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonist Based on the Macrocyclic Metal Chelator NODIA-Me-Reference-Cited by-同舟云学术

Radiometal Complexes as Pharmacokinetic Modifiers: A Potent ⁶⁸Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonist Based on the Macrocyclic Metal Chelator NODIA-Me

Published:2023-11-18 Issue:12 Volume:20 Page:6463-6473
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Schreck Moritz-Valentin¹,Burgard Caroline¹,Schmidtke Alexander¹,Hierlmeier Ina¹,Stemler Tobias¹,Maus Stephan¹,Rosar Florian¹,Jung Martin²,Speicher Andreas³,Ezziddin Samer¹,Holland Jason P.⁴^ORCID,Bartholomä Mark D.¹^ORCID

Affiliation:

1. Department of Nuclear Medicine, Saarland University−Medical Center, Kirrbergerstrasse, D-66421 Homburg, Germany

2. Department of Medical Biochemistry and Molecular Biology, Saarland University, D-66421 Homburg, Germany

3. Department of Organic Chemistry, Saarland University, D-66123 Saarbrücken, Germany

4. Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland

Funder

Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung

Deutsche Forschungsgemeinschaft

Universit?t des Saarlandes

Universit?t Z?rich

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00852

Reference39 articles.

1. Molecular imaging in oncology: Current impact and future directions

2. Molecular imaging for personalized cancer care

3. Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: Molecular basis for dual targeting of tumoral vasculature

4. Gastrin-Releasing Peptide Receptors in Non-Neoplastic and Neoplastic Human Breast

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics;Pharmaceutics;2024-04-08